Galectin-3 expression in colorectal cancer: relation to invasion and metastasis.
Galectin-3 expression in colorectal cancer: relation to invasion and metastasis.
复制标题
DOI:
--
复制
发表时间:
2007-07
影响因子:
2
通讯作者:
Kaori Tsuboi;T. Shimura;N. Masuda;M. Ide;S. Tsutsumi;S. Yamaguchi;T. Asao;H. Kuwano
中科院分区:
文献类型:
--
作者:
Kaori Tsuboi;T. Shimura;N. Masuda;M. Ide;S. Tsutsumi;S. Yamaguchi;T. Asao;H. Kuwano
BACKGROUND Galectin-3, a beta-galactoside-binding protein, has been associated with various biological processes, such as cell adhesion, recognition, proliferation, differentiation and apoptosis. The aim of this study was to determine the relationship of galectin-3 expression to clinicopathological findings in patients with colorectal cancer. Furthermore, the correlation between the expression of galectin-3 and beta-catenin, and the Ki-67 labeling index were investigated. MATERIALS AND METHODS Immunohistochemical assessment of galectin-3, beta-catenin and Ki-67 expression was performed on samples from 108 patients with colorectal cancer. The expression of galectin-3 was classified at the tumor surface and the invasive front, and its relationship with clinicopathological factors was considered from a statistical viewpoint. RESULTS There was significant liver metastasis when the expression of galectin-3 was lower at the invasive front of a tumor compared to its surface (p = 0.04). There were also significant correlations between beta-catenin expression at the tumor surface and liver metastasis and tumor stage (p = 0.03, p = 0.04 respectively). CONCLUSION The reduction of galectin-3 expression is associated with the invasion and metastasis of colorectal cancer. A possible involvement of galectin-3 expression in tumor invasion, metastasis and proliferation in patients with colorectal cancer is suggested.